Our previous study, involving immunohistochemical analysis of tissue microarrays from 275 patients with ESCC who underwent complete three‐field lymphadenectomy, showed that Akt1 activation correlates with poor prognosis.71 Here, AKT1 is linked to esophageal squamous cell carcinoma.